These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
356 related items for PubMed ID: 17389231
1. Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages. Meinen S, Barzaghi P, Lin S, Lochmüller H, Ruegg MA. J Cell Biol; 2007 Mar 26; 176(7):979-93. PubMed ID: 17389231 [Abstract] [Full Text] [Related]
4. Laminin alpha1 chain improves laminin alpha2 chain deficient peripheral neuropathy. Gawlik KI, Li JY, Petersén A, Durbeej M. Hum Mol Genet; 2006 Sep 15; 15(18):2690-700. PubMed ID: 16893907 [Abstract] [Full Text] [Related]
5. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice. Ringelmann B, Röder C, Hallmann R, Maley M, Davies M, Grounds M, Sorokin L. Exp Cell Res; 1999 Jan 10; 246(1):165-82. PubMed ID: 9882526 [Abstract] [Full Text] [Related]
6. A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination. Patton BL, Wang B, Tarumi YS, Seburn KL, Burgess RW. J Cell Sci; 2008 May 15; 121(Pt 10):1593-604. PubMed ID: 18430779 [Abstract] [Full Text] [Related]
7. Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric mice. Saito F, Masaki T, Saito Y, Nakamura A, Takeda S, Shimizu T, Toda T, Matsumura K. J Neurochem; 2007 Jun 15; 101(6):1712-22. PubMed ID: 17326765 [Abstract] [Full Text] [Related]
8. Expression of mouse agrin in normal, denervated and dystrophic muscle. Eusebio A, Oliveri F, Barzaghi P, Ruegg MA. Neuromuscul Disord; 2003 Jun 15; 13(5):408-15. PubMed ID: 12798796 [Abstract] [Full Text] [Related]
11. Adeno-Associated Virus-Mediated Mini-Agrin Delivery Is Unable to Rescue Disease Phenotype in a Mouse Model of Limb Girdle Muscular Dystrophy Type 2I. Vannoy CH, Zhou H, Qiao C, Xiao X, Bang AG, Lu QL. Am J Pathol; 2017 Feb 15; 187(2):431-440. PubMed ID: 28107841 [Abstract] [Full Text] [Related]
12. Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice. Gawlik K, Miyagoe-Suzuki Y, Ekblom P, Takeda S, Durbeej M. Hum Mol Genet; 2004 Aug 15; 13(16):1775-84. PubMed ID: 15213105 [Abstract] [Full Text] [Related]
14. The role of dystroglycan, a novel receptor of laminin and agrin, in cell differentiation. Matsumura K, Yamada H, Saito F, Sunada Y, Shimizu T. Histol Histopathol; 1997 Jan 15; 12(1):195-203. PubMed ID: 9046055 [Abstract] [Full Text] [Related]
18. Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A. Doe JA, Wuebbles RD, Allred ET, Rooney JE, Elorza M, Burkin DJ. J Cell Sci; 2011 Jul 01; 124(Pt 13):2287-97. PubMed ID: 21652631 [Abstract] [Full Text] [Related]
19. Overexpression of LARGE suppresses muscle regeneration via down-regulation of insulin-like growth factor 1 and aggravates muscular dystrophy in mice. Saito F, Kanagawa M, Ikeda M, Hagiwara H, Masaki T, Ohkuma H, Katanosaka Y, Shimizu T, Sonoo M, Toda T, Matsumura K. Hum Mol Genet; 2014 Sep 01; 23(17):4543-58. PubMed ID: 24722207 [Abstract] [Full Text] [Related]
20. Overexpression of the cytotoxic T cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A. Xu R, Chandrasekharan K, Yoon JH, Camboni M, Martin PT. Am J Pathol; 2007 Jul 01; 171(1):181-99. PubMed ID: 17591965 [Abstract] [Full Text] [Related] Page: [Next] [New Search]